Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery- Rein 3D Anxiety

NCT ID: NCT06035211

Last Updated: 2025-06-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

192 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-19

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate the impact of showing and handling a three-dimensional modelization of a patient's tumoral kidney the day before his nephron-sparing surgery. The main outcome measure was the effect on anxiety assessed via the STAI state score. 3 types of pre-operative information were compared (3D virtual model, 3D printed model, and information) using a randomization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Announcement of serious illnesses and especially cancerous disease has major impacts on one's psychological field. Need of surgery can create even other fears due to its unknown nature. Use of tools to decrease anxiety and enhance understanding prior to surgery is a key point in comprehensive care that is way not enough promoted for now. In the field of surgery, available methods to deal with pre-operative anxiety are massively represented by anxiolytics drugs, only few other devices were evaluated.

Technological development in healthcare has seen the rising of three-dimensional media, especially in surgery, for procedure planning. There is no doubt that this tool is effective in helping surgeons regarding the studies published within the past few years but there is no such evidence concerning the benefit for patients. Some authors report improvement of patients understanding and great satisfaction referring to the usefulness of this tool. But none of these papers evaluated anxiety.

The goal of this research is to measure the effect of a personalized three-dimensional model of patients' tumoral kidney on peri-operative anxiety.

For this purpose this clinical trial is designed as following: a total of 234 (78\*3) patients planned to have a nephron-sparing surgery for kidney tumor are going to be randomly assign in 3 different groups. Inside the 2 interventional groups, patients' kidneys will be modelled in three dimensions, but in one of the two groups, the model will be 3D-printed. The control group will include patients for whom the pre-operative information will be made based on standardized information letter from the French Urological Association.

Before surgery, during a preoperative therapeutic education consultation, 3D models will be presented to the patients according to the allocated study group. All patients will have to complete questionnaires to assess their anxiety level, their quality of life, their health literacy level and their understanding of disease and surgical procedure.

One month after surgery, during the post-operative consultation, patients will also fill out the different questionnaires to assess their anxiety level, quality of life, and level of litteracy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tumoral Kidney

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual 3D model group

exchange time with the virtual 3D model of the kidney to be operated on as information support

Group Type ACTIVE_COMPARATOR

3D model pré-operative education

Intervention Type OTHER

Before surgery, during a preoperative therapeutic education consultation, 3D models will be presented to the patients according to the allocated study group

3D Printed Model Group

eexchange time with the printed three-dimensional model of the kidney to be operated on as information support

Group Type ACTIVE_COMPARATOR

3D model pré-operative education

Intervention Type OTHER

Before surgery, during a preoperative therapeutic education consultation, 3D models will be presented to the patients according to the allocated study group

Control group

discussion time with the patient information sheet of the French Association of Urology (AFU) as information support

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3D model pré-operative education

Before surgery, during a preoperative therapeutic education consultation, 3D models will be presented to the patients according to the allocated study group

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients (≥ 18 years of age)
* Scheduled surgical management by laparoscopic partial nephrectomy with robotic assistance for kidney tumor
* Unilateral kidney tumor or 1st surgery for bilateral involvement
* Consent expressed for integration of the UroCCR cohort,
* Expressed consent for participation in the 3D Anxiety study.
* Patients affiliated or benefiting from a social security plan

Exclusion Criteria

* Refusal of consent or participation
* Difficulty understanding and expressing oneself in French
* Patient under guardianship or curatorship
* No preoperative CT scan available for 3D modeling
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bordeaux

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Christophe BERNHARD, Professeur

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Bordeaux

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU d'ANGERS

Angers, , France

Site Status RECRUITING

CHU de Bordeaux

Bordeaux, , France

Site Status RECRUITING

CHU de CAEN

Caen, , France

Site Status RECRUITING

Hôpital Kremlin-Bicêtre

Le Kremlin-Bicêtre, , France

Site Status RECRUITING

CHU de La CONCEPTION

Marseille, , France

Site Status RECRUITING

CHU de NANTES

Nantes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-Christophe BERNHARD, Professeur

Role: CONTACT

05 57 82 03 50

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pierre BIGOT, Pr.

Role: primary

Jean-Christophe BERNHARD, Pr.

Role: primary

Thibaut WAECKEL, Dr.

Role: primary

Sébastien PARIER, Dr.

Role: primary

Romain BOISSIER, Pr.

Role: primary

Stéphane De VERGIE, Dr.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUBX 2022/18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Use of Predigraft in Kidney Transplant Patients
NCT04969757 ACTIVE_NOT_RECRUITING NA